Advertisement

Topics

Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Company Profile

02:19 EDT 25th June 2018 | BioPortfolio

Spectrum Pharmaceuticals, a biotechnology company with a primary focus in oncology and hematology, currently markets two oncology drugs, FUSILEV® and ZEVALIN®. In addition, Spectrum has two drugs, apaziquone and belinostat, in late stage development. Spectrum also has a diversified pipeline of novel drug candidates. Spectrum’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial drug products. Spectrum has aggressive business development and commercial operation teams that support a robust drug development program encompassing clinical development, medical research, regulatory affairs, biostatistics and data management. Spectrum also leverages the expertise of its worldwide partners to assist in the execution of its strategy. For more information, please visit Spectrum’s website at www.sppirx.com.


News Articles [1764 Associated News Articles listed on BioPortfolio]

Spectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Markets' Fourteenth ...

Spectrum Pharmaceuticals, Inc.Shiv KapoorVice President, Strategic Planning & Investor Relations702-835-6300InvestorRelations@sppirx.com Read more...

Company Profile for SPECTRUM PHARMACEUTICALS

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. S...

ClariVest Asset Management LLC Reduces Holdings in Spectrum Pharmaceuticals

ClariVest Asset Management LLC lowered its stake in Spectrum Pharmaceuticals by 10.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owne...

MD Anderson grants exclusive poziotinib IP rights to Spectrum

MD Anderson Cancer Center granted Spectrum Pharmaceuticals Inc. exclusive rights to intellectual property surrounding certain methods of use of the epidermal growth factor receptor tyrosine kinase/pan...

Kurt A. Gustafson Sells 4,350 Shares of Spectrum Pharmaceuticals (SPPI) Stock

Spectrum Pharmaceuticals CFO Kurt A. Gustafson sold 4,350 shares of the stock in a transaction on Wednesday, March 28th. The stock was sold at an average price of $16.35, for a total value of $71,122....

Deals this week: Neurana, BioClin Therapeutics, CStone Pharmaceuticals

Neurana Pharmaceuticals Inc has raised $60m in a series A financing led by Sofinnova Ventures along with participation from New Leaf...Read More... The post Deals this week: Neurana, BioClin Therapeu...

Spectrum Pharmaceuticals: What's Next For Poziotinib

Deals this week: Melinta Therapeutics, Cipher Pharmaceuticals, Baxter International

Melinta Therapeutics plans to raise $114.88m by issuing 6,920,714 shares of its common stock, priced at $16.6 a share. The US-based...Read More... The post Deals this week: Melinta Therapeutics, Ciph...

PubMed Articles [1226 Associated PubMed Articles listed on BioPortfolio]

A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery.

Psychotic spectrum disorder (PSD) links the syndromes of bipolar disorder, psychotic depression, and schizophrenia, often viewed as unique disorders.

The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics.

This review will discuss the expanding clinical spectrum of paroxysmal movement disorders and therapeutic options in light of emerging genotypic heterogeneity in these conditions.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

The purpose of this manuscript is to review the evidence generated by clinical trials of pharmaceuticals in autism spectrum disorder (ASD), describe challenges in the conduct of such trials, and discu...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Clinical Trials [1029 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [2924 Associated Companies listed on BioPortfolio]

Allos Therapeutics, Inc.

Allos Therapeutics, Inc. (Nasdaq: ALTH) is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. Allos is currentl...

Spectrum Pharmaceuticals and Allos Therapeutics, Inc.

Spectrum Pharmaceuticals, a biotechnology company with a primary focus in oncology and hematology, currently markets two oncology drugs, FUSILEV® and ZEVALIN®. In addition, ...

Allos Therapeutics Incorporated

Allos Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments. Since 1994, we have been committed to improving the health...

Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a specialty pharmaceutical company engaged in the business of acquiring, developing and commercializing prescription drug products for the treatment of cancer and other unm...

Pro-Pharmaceuticals, Inc.

Pro-Pharmaceuticals, OTCBB: PRWP, is the leader in the field of Galectin therapeutics and is engaged in the discovery, development and commercialization of therapeutics that targe...

More Information about "Spectrum Pharmaceuticals and Allos Therapeutics, Inc." on BioPortfolio

We have published hundreds of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. news stories on BioPortfolio along with dozens of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Clinical Trials and PubMed Articles about Spectrum Pharmaceuticals and Allos Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Companies in our database. You can also find out about relevant Spectrum Pharmaceuticals and Allos Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record